Sam Bazzi

Dr. Sam Bazzi


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 February 2025 in Addiction Biology
Verified
Journal Article
Open access
SBSam Bazzi
Sam Bazzi
CMCole Maguire
Cole Maguire
DMDayne Mayfield
Dayne Mayfield
EMEsther Melamed
Esther Melamed
Oligodendrocytes are a key cell type within the central nervous system (CNS) that generates the myelin sheath covering axons, enabling fast propagation of neuronal signals. Alcohol consumption is known to affect oligodendrocytes and white matter in the CNS. However, most studies have focused on foetal alcohol spectrum disorder and severe alcohol use disorder. Additionally, the impact of alcohol dosage on oligodendrocytes has not been previously investigated. In this study, we evaluated transcriptomic changes in C57BL6/J cultured mature oligodendrocytes following exposure to moderate and high concentrations of alcohol. We found that high concentrations of alcohol elicited gene expression changes across a wide range of biological pathways, including myelination, protein translation, integrin signalling, cell cycle regulation and inflammation. Further, our results demonstrate that transcriptomic changes are indeed dependent on alcohol concentration, with moderate and high concentrations of alcohol provoking distinct gene expression profiles. In conclusion, our study demonstrates that alcohol‐induced transcriptomic changes in oligodendrocytes are concentration‐dependent and may have critical downstream impacts on myelin production. Targeting alcohol‐induced changes in cell cycle regulation, integrin signalling, inflammation or protein translation regulation may uncover mechanisms for modulating myelin production or inhibition. Furthermore, gaining a deeper understanding of alcohol's effects on oligodendrocyte demyelination and remyelination could help uncover therapeutic pathways that can be utilized independently of alcohol to aid in remyelinating drug design.

22 September 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
SBSam Bazzi
Sam Bazzi
CMCole Maguire
Cole Maguire
RMR. Dayne Mayfield
R. Dayne Mayfield
EMEsther Melamed
Esther Melamed
Oligodendrocytes are a key cell type within the central nervous system (CNS) that generate the myelin sheath covering axons, enabling fast propagation of neuronal signals. Alcohol consumption is known to affect oligodendrocytes and white matter in the CNS. However, most studies have focused on fetal alcohol spectrum disorder and severe alcohol use disorder. Additionally, the impact of alcohol dosage on oligodendrocytes has not been previously investigated. In this study, we evaluated transcriptomic changes in C57BL6/J cultured mature oligodendrocytes following exposure to moderate and high concentrations of alcohol. We found that high concentrations of alcohol elicited gene expression changes across a wide range of biological pathways, including myelination, protein translation, integrin signaling, cell cycle regulation, and inflammation. Further, our results demonstrate that transcriptomic changes are indeed dependent on alcohol concentration, with moderate and high concentrations of alcohol provoking distinct gene expression profiles. In conclusion, our study demonstrates that alcohol-induced transcriptomic changes in oligodendrocytes are concentration-dependent and may have critical downstream impacts on myelin production. Targeting alcohol-induced changes in cell cycle regulation, integrin signaling, inflammation, or protein translation regulation may uncover mechanisms for modulating myelin production or inhibition. Furthermore, gaining a deeper understanding of alcohol’s effects on oligodendrocyte demyelination and remyelination could help uncover therapeutic pathways that can be utilized independent of alcohol to aid in remyelinating drug design.

7 May 2026 in World Neurosurgery
Verified
Journal Article
Open access
SOSean O'LEary
Sean O'LEary
MSMilan Sivakumar
Milan Sivakumar
GWGillian Witten
Gillian Witten
SBSam Bazzi
Sam Bazzi
DADhillon Advano
Dhillon Advano
CBCarlos Bagley
Carlos Bagley
Surgery for adult spinal deformity (ASD) can result in complications such as proximal junctional kyphosis (PJK), pseudoarthrosis, hardware failure, and surgical site infection. This study sought to identify specific risk factors for these complications in ASD patients. Patients undergoing long-segment thoracolumbar fusion (>4 levels) for ASD between 2016 and 2021 were included. Univariate and multivariable analyses assessed preoperative risk factors for complications. A subgroup analysis of patients undergoing ≥7-level fusion constructs was also performed. Among 235 patients (66% female; mean age 70 years; mean body mass index [BMI] 28), higher BMI was associated with hardware failure (odds ratio [OR]: 1.087, 95% CI: 1.023-1.157, P = 0.007). Frailty measured by modified 11-item Frailty Index and dual-energy x-ray absorptiometry (DXA)-defined bone health were not significantly associated with the studied complications. Lower preoperative sagittal vertical axis (SVA) was associated with higher pseudoarthrosis risk (OR: 0.841, 95% CI: 0.716-0.977, P = 0.023). Smaller L3 vertebral surface area (OR: 0.997, 95% CI: 0.993-0.999, P = 0.023), left L4 psoas area (OR: 0.998, 95% CI: 0.995-1.000, P = 0.043), and L4 total psoas area (OR: 0.998, 95% CI: 0.997-1.000, P = 0.015) were associated with increased PJK risk. Other radiographic measures were not significantly associated with complications. Findings were generally consistent in the ≥7-level fusion subgroup. In this single-center cohort, frailty, DXA-defined osteoporosis, and most radiographic alignment parameters were not significantly associated with postoperative complications, although these findings should be interpreted cautiously given limitations in frailty measurement, incomplete bone health assessment, and cohort power. BMI, sagittal alignment, and paraspinal muscle mass showed more consistent associations with adverse outcomes.

13 March 2026 in Biomolecules
Verified
Journal Article
Open access
PDF file
ANAdriana Souto Pereira Nuncio
Adriana Souto Pereira Nuncio
KMKatherine Motovilov
Katherine Motovilov
MWMaxwell Weed
Maxwell Weed
SSSimali Shah
Simali Shah
SBSam Bazzi
Sam Bazzi
EMEsther Melamed
Esther Melamed
Both epidemiological studies and prior work in animal models suggest that moderate-dose alcohol reduces disease severity across several autoimmune conditions, including multiple sclerosis (MS). However, the mechanisms underlying the potentially beneficial effects of alcohol and how these effects may change with alcohol dose in autoimmunity remain underexplored. In this study, we characterize the effects of chronic, high-dose ethanol consumption in experimental autoimmune encephalomyelitis (EAE), a murine model of MS, by examining EAE disease severity, gut microbial composition, and peripheral cell immunophenotypes. We found that high-dose ethanol-fed males exhibited a significant amelioration in peak EAE disease severity, in association with decreased T cell activation and B cell proportions. Concurrently, we observed proinflammatory shifts in gut microbiota and hepatic lipid accumulation. Our results suggest that high dose ethanol may benefit autoimmune neuroinflammation in EAE through immunosuppressive effects on adaptive immunity, however its toxic systemic effects preclude the use of alcohol as an immunomodulator in MS. Overall, our findings reveal a mechanistic basis for alcohol’s beneficial properties in autoimmunity and could inform the development of more targeted disease modifying therapies that recapitulate these benefits without alcohol-associated toxicity.